Diamedica Therapeutics Inc. · NASDAQ:DMAC
TomEnterprise AB reported a 16.28% stake in Diamedica Therapeutics Inc. (Schedule 13G/A)
Event Jul 23, 2025 · Filed Jul 30, 2025
TomEnterprise AB reported a 16.28% stake in Diamedica Therapeutics Inc., 8,383,577 shares, as a passive investor on Jul 23, 2025. Filed Jul 30, 2025 (Schedule 13G/A).
- Stake
- 16.28%
- Shares
- 8,383,577
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| TomEnterprise AB | 16.28% | 8,383,577 |
| TomEnterprise Private AB | 16.28% | 8,383,577 |
| Thomas von Koch | 16.28% | 8,383,577 |
Source
Related
- Diamedica Therapeutics Inc.
- TomEnterprise AB
- Diamedica Therapeutics Inc. shareholders
- Form 4 · Pauls Dietrich John · Aug 12, 2026
- Schedule 13G/A · John Fichthorn · Feb 17, 2026
- Schedule 13G/A · Cooperman Leon G · Feb 17, 2026
- Schedule 13G/A · Trill AB · Feb 6, 2026
- Schedule 13G/A · Richard Jacinto II · Nov 7, 2025